|
1
|
Hansson GK, Libby P and Tabas I:
Inflammation and plaque vulnerability. J Intern Med. 278:483–493.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Vries MR and Quax PH: Plaque
angiogenesis and its relation to inflammation and atherosclerotic
plaque destabilization. Curr Opin Lipidol. 27:499–506. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: Vascular smooth muscle cell in atherosclerosis. Acta Physiol
(Oxf). 214:33–50. 2015. View Article : Google Scholar
|
|
4
|
Meng Z, Yan C, Deng Q, Gao DF and Niu XL:
Curcumin inhibits LPS-induced inflammation in rat vascular smooth
muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways.
Acta Pharmacol Sin. 34:901–911. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Son YH, Jeong YT, Lee KA, Choi KH, Kim SM,
Rhim BY and Kim K: Roles of MAPK and NF-kappaB in interleukin-6
induction by lipopolysaccharide in vascular smooth muscle cells. J
Cardiovasc Pharmacol. 51:71–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dickson BC and Gotlieb AI: Towards
understanding acute destabilization of vulnerable atherosclerotic
plaques. Cardiovasc Pathol. 12:237–248. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Minguet S, Dopfer EP, Pollmer C,
Freudenberg MA, Galanos C, Reth M, Huber M and Schamel WW: Enhanced
B-cell activation mediated by TLR4 and BCR crosstalk. Eur J
Immunol. 38:2475–2487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roshan MH, Tambo A and Pace NP: The Role
of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis. Int
J Inflam. 2016:15328322016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu Z, Zhang X, Li Y, Jin J and Huang Y:
TLR4 antagonist reduces early-stage atherosclerosis in diabetic
apolipoprotein E-deficient mice. J Endocrinol. 216:61–71. 2013.
View Article : Google Scholar
|
|
10
|
Edfeldt K, Swedenborg J, Hansson GK and
Yan ZQ: Expression of toll-like receptors in human atherosclerotic
lesions: A possible pathway for plaque activation. Circulation.
105:1158–1161. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Michelsen KS, Wong MH, Shah PK, Zhang W,
Yano J, Doherty TM, Akira S, Rajavashisth TB and Arditi M: Lack of
Toll-like receptor 4 or myeloid differentiation factor 88 reduces
atherosclerosis and alters plaque phenotype in mice deficient in
apolipoprotein E. Proc Natl Acad Sci USA. 101:10679–10684. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ajibade AA, Wang HY and Wang RF: Cell
type-specific function of TAK1 in innate immune signaling. Trends
Immunol. 34:307–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao X, Li G, Bai Q, Xu H and Lü C:
Taraxerol inhibits LPS-induced inflammatory responses through
suppression of TAK1 and Akt activation. Int Immunopharmacol.
15:316–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang J, Little PJ and Xu S:
Atheroprotective effects and molecular targets of tanshinones
derived from herbal medicine danshen. Med Res Rev. 38:201–228.
2018. View Article : Google Scholar
|
|
15
|
Fan K, Li S, Liu G, Yuan H, Ma L and Lu P:
Tanshinone IIA inhibits high glucose-induced proliferation,
migration and vascularization of human retinal endothelial cells.
Mol Med Rep. 16:9023–9028. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, Jiao Y, Wang H, Shang Q, Lu F, Huang
L, Liu J, Xu H and Chen K: Sodium tanshinone IIA sulfate adjunct
therapy reduces high-sensitivity C-reactive protein level in
coronary artery disease patients: A randomized controlled trial.
Sci Rep. 7:174512017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu H, Zhai C, Qian G, Gu A, Liu J, Ying F,
Xu W, Jin D, Wang H, Hu H, et al: Protective effects of tanshinone
IIA on myocardial ischemia reperfusion injury by reducing oxidative
stress, HMGB1 expression, and inflammatory reaction. Pharm Biol.
53:1752–1758. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sui H, Zhao J, Zhou L, Wen H, Deng W, Li
C, Ji Q, Liu X, Feng Y, Chai N, et al: Tanshinone IIA inhibits
β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in
normoxic and HIF-1α in hypoxic microenvironments in human
colorectal cancer. Cancer Lett. 403:86–97. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fan G, Jiang X, Wu X, Fordjour PA, Miao L,
Zhang H, Zhu Y and Gao X: Anti-Inflammatory activity of tanshinone
IIA in LPS-stimulated RAW264.7 macrophages via miRNAs and
TLR4-NF-κB PATHWAY. Inflammation. 39:375–384. 2016. View Article : Google Scholar
|
|
20
|
National Research Council: Guide for the
Care and Use of Laboratory Animals. National Academy Press;
Washington, DC: 1996
|
|
21
|
Griendling KK, Taubman MB, Akers M,
Mendlowitz M and Alexander RW: Characterization of
phosphatidylinositol-specific phospholipase C from cultured
vascular smooth muscle cells. J Biol Chem. 266:15498–15504.
1991.PubMed/NCBI
|
|
22
|
Cho JY, Baik KU, Jung JH and Park MH: In
vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene
lactone, from Saussurea lappa. Eur J Pharmacol. 398:399–407. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou W, Wang G, Zhao X, Xiong F, Zhou S,
Peng J, Cheng Y, Xu S and Xu X: A multiplex qPCR gene dosage assay
for rapid genotyping and large-scale population screening for
deletional α-thalassemia. J Mol Diagn. 15:642–651. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao L, Pan D, Li D, Zhang Y, Chen Q, Xu T,
Li W and Wu W: Relation between anti-atherosclerotic effects of
IRAK4 and modulation of vascular smooth muscle cell phenotype in
diabetic rats. Am J Transl Res. 8:899–910. 2016.PubMed/NCBI
|
|
25
|
Meng Z, Gao P, Chen L, Peng J, Huang J, Wu
M, Chen K and Zhou Z: Artificial zinc-finger transcription factor
of A20 suppresses restenosis in sprague dawley rats after carotid
injury via the PPARα pathway. Mol Ther Nucleic Acids. 15:123–131.
2017. View Article : Google Scholar
|
|
26
|
Chen FL, Yang ZH, Wang XC, Liu Y, Yang YH,
Li LX, Liang WC, Zhou WB and Hu RM: Adipophilin affects the
expression of TNF-alpha, MCP-1, and IL-6 in THP-1 macrophages. Mol
Cell Biochem. 337:193–199. 2010. View Article : Google Scholar
|
|
27
|
Konev IuV and Lazebnik LB: Endotoxin (LPS)
in the pathogenesis of atherosclerosis. Eksp Klin Gastroenterol.
15–26. 2011.In Russian.
|
|
28
|
Li Y, Guo Y, Chen Y, Wang Y, You Y, Yang
Q, Weng X, Li Q, Zhu X, Zhou B, et al: Establishment of an
interleukin-1β-induced inflammation-activated endothelial
cell-smooth muscle cell-mononuclear cell co-culture model and
evaluation of the anti-inflammatory effects of tanshinone IIA on
atherosclerosis. Mol Med Rep. 12:1665–1676. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li J, Zheng Y, Li MX, Yang CW and Liu YF:
Tanshinone IIA alleviates lipopolysaccharide-induced acute lung
injury by downregulating TRPM7 and pro-inflammatory factors. J Cell
Mol Med. 22:646–654. 2018. View Article : Google Scholar
|
|
30
|
Cheng J, Chen T, Li P, Wen J, Pang N,
Zhang L and Wang L: Sodium tanshinone IIA sulfonate prevents
lipopolysaccha-ride-induced inflammation via suppressing nuclear
factor-κB signaling pathway in human umbilical vein endothelial
cells. Can J Physiol Pharmacol. 96:26–31. 2018. View Article : Google Scholar
|
|
31
|
Wang B, Ge Z, Cheng Z and Zhao Z:
Tanshinone IIA suppresses the progression of atherosclerosis by
inhibiting the apoptosis of vascular smooth muscle cells and the
proliferation and migration of macrophages induced by ox-LDL. Biol
Open. 6:489–495. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shaw CA, Taylor EL, Megson IL and Rossi
AG: Nitric oxide and the resolution of inflammation: Implications
for atherosclerosis. Mem Inst Oswaldo Cruz. 100(Suppl 1): S67–S71.
2005. View Article : Google Scholar
|
|
33
|
Caillaud D, Galinier M, Elbaz M, Carrié D,
Puel J, Fauvel JM and Arnal JF: Atherosclerosis-the role of nitric
oxide. Presse Med. 30:41–44. 2001.In French. PubMed/NCBI
|
|
34
|
Förstermann U, Xia N and Li H: Roles of
vascular oxidative stress and nitric oxide in the pathogenesis of
atherosclerosis. Circ Res. 120:713–735. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Asiimwe N, Yeo SG, Kim MS, Jung J and
Jeong NY: Nitric oxide: Exploring the contextual link with
Alzheimer’s disease. Oxid Med Cell Longev. 2016:72057472016.
View Article : Google Scholar
|
|
36
|
Heydarpour P, Rahimian R, Fakhfouri G,
Khoshkish S, Fakhraei N, Salehi-Sadaghiani M, Wang H, Abbasi A,
Dehpour AR and Ghia JE: Behavioral despair associated with a mouse
model of Crohn’s disease: Role of nitric oxide pathway. Prog
Neuropsychopharmacol Biol Psychiatry. 64:131–141. 2016. View Article : Google Scholar
|
|
37
|
Detmers PA, Hernandez M, Mudgett J,
Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock
J, et al: Deficiency in inducible nitric oxide synthase results in
reduced atherosclerosis in apolipoprotein E-deficient mice. J
Immunol. 165:3430–3435. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu XH, Wang XL, Xin H, Wu D, Xin XM, Miao
L, Zhang QY, Zhou Y, Liu Q, Zhang Q and Zhu YZ: Induction of heme
oxygenase-1 by sodium 9-hydroxyltanshinone IIA sulfonate derivative
contributes to inhibit LPS-mediated inflammatory response in
macrophages. Cell Physiol Biochem. 36:1316–1330. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gargiulo S, Gamba P, Testa G, Rossin D,
Biasi F, Poli G and Leonarduzzi G: Relation between TLR4/NF-κB
signaling pathway activation by 27-hydroxycholesterol and
4-hydroxynon-enal, and atherosclerotic plaque instability. Aging
Cell. 14:569–581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nunes KP, Bomfim GF, Toque HA, Szasz T and
Clinton Webb R: Toll-like receptor 4 (TLR4) impairs nitric oxide
contributing to Angiotensin II-induced cavernosal dysfunction. Life
Sci. 191:219–226. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
He A, Ji R, Shao J, He C, Jin M and Xu Y:
TLR4-MyD88-TRAF6-TAK1 complex-mediated NF-κB activation contribute
to the anti-inflammatory effect of V8 in LPS-induced human cervical
cancer SiHa cells. Inflammation. 39:172–181. 2016. View Article : Google Scholar
|
|
42
|
Shim JH, Xiao C, Paschal AE, Bailey ST,
Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, et al:
TAK1, but not TAB1 or TAB2, plays an essential role in multiple
signaling pathways in vivo. Genes Dev. 19:2668–2681. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu WY, Yan H, Wang XB, Gui YZ, Gao F, Tang
XL, Qin YL, Su M, Chen T and Wang YP: Sodium tanshinone IIA silate
inhibits high glucose-induced vascular smooth muscle cell
proliferation and migration through activation of AMP-activated
protein kinase. PLoS One. 9:e949572014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen CL, Chen JT, Liang CM, Tai MC, Lu DW
and Chen YH: Silibinin treatment prevents endotoxin-induced uveitis
in rats in vivo and in vitro. PLoS One. 12:e01749712017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bhatia HS, Baron J, Hagl S, Eckert GP and
Fiebich BL: Rice bran derivatives alleviate microglia activation:
Possible involvement of MAPK pathway. J Neuroinflammation.
13:148–155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ghosh S and Dass JF: Study of pathway
cross-talk interactions with NF-κB leading to its activation via
ubiquitination or phosphorylation: A brief review. Gene.
584:97–109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen XW and Zhou SF: Inflammation,
cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis. Drug
Des Devel Ther. 9:2941–2946. 2015.
|
|
48
|
Kim KJ, Yoon KY, Yoon HS, Oh SR and Lee
BY: Brazilein suppresses inflammation through inactivation of
IRAK4-NF-κB pathway in LPS-induced Raw264.7 macrophage cells. Int J
Mol Sci. 16:27589–27598. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang HL, Huang PJ, Liu YR, Kumar KJ, Hsu
LS, Lu TL, Chia YC, Takajo T, Kazunori A and Hseu YC: Toona
sinensis inhibits LPS-induced inflammation and migration in
vascular smooth muscle cells via suppression of reactive oxygen
species and NF-κB signaling pathway. Oxid Med Cell Longev.
2014:9013152014. View Article : Google Scholar
|
